As part of the commercial real estate industry, the life science market is dwarfed by its industrial sibling. Where the latter comprises 14 billion square feet of developed space nationwide, the life science sector includes 150 million square feet. It may be a niche segment, but it’s drawing outsized interest from private investors and federal […]
The emergence of the COVID-19 Delta variant has played an important part in delaying some planned returns to the office. However, many businesses have been well equipped to adapt to the continually shifting economic environment. While some companies are pushing reopening dates later in the fall or to next year, other firms (such as United […]
Rising consumer spending, greater mobility and improved vaccination rates are contributing significantly to bringing back commercial activity to markets that have been impacted by challenges associated with social distancing, limited travel and density. While long-term space planning remains somewhat fluid, flexibility on concessions rather than on asking rates has contributed to sustained growth in average […]
Life sciences firms are under intense pressure right now to research and produce viable COVID-19 vaccines, and their workplaces and labs need to support their vital work. While many current pharmaceutical office trends will continue, new priorities are emerging that include accessible outdoor space, increased security and equalized workplace technology. Despite the economic challenges of […]